These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16765892)

  • 21. Edge strand engineering prevents native-like aggregation in Sulfolobus solfataricus acylphosphatase.
    de Rosa M; Bemporad F; Pellegrino S; Chiti F; Bolognesi M; Ricagno S
    FEBS J; 2014 Sep; 281(18):4072-84. PubMed ID: 24893801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
    J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural models of amyloid-like fibrils.
    Nelson R; Eisenberg D
    Adv Protein Chem; 2006; 73():235-82. PubMed ID: 17190616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A molecular dynamics study of acylphosphatase in aggregation-promoting conditions: the influence of trifluoroethanol/water solvent.
    Flöck D; Daidone I; Di Nola A
    Biopolymers; 2004 Dec; 75(6):491-6. PubMed ID: 15526333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological function in a non-native partially folded state of a protein.
    Bemporad F; Gsponer J; Hopearuoho HI; Plakoutsi G; Stati G; Stefani M; Taddei N; Vendruscolo M; Chiti F
    EMBO J; 2008 May; 27(10):1525-35. PubMed ID: 18451804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A universal pathway for amyloid nucleus and precursor formation for insulin.
    Nayak A; Sorci M; Krueger S; Belfort G
    Proteins; 2009 Feb; 74(3):556-65. PubMed ID: 18655073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformation-dependent anti-amyloid oligomer antibodies.
    Kayed R; Glabe CG
    Methods Enzymol; 2006; 413():326-44. PubMed ID: 17046404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of randomizing the Sup35NM prion domain sequence on formation of amyloid fibrils in vitro.
    Liu Y; Wei H; Wang J; Qu J; Zhao W; Tao H
    Biochem Biophys Res Commun; 2007 Feb; 353(1):139-46. PubMed ID: 17166483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach.
    Teplow DB; Lazo ND; Bitan G; Bernstein S; Wyttenbach T; Bowers MT; Baumketner A; Shea JE; Urbanc B; Cruz L; Borreguero J; Stanley HE
    Acc Chem Res; 2006 Sep; 39(9):635-45. PubMed ID: 16981680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure, conformational stability, and enzymatic properties of acylphosphatase from the hyperthermophile Sulfolobus solfataricus.
    Corazza A; Rosano C; Pagano K; Alverdi V; Esposito G; Capanni C; Bemporad F; Plakoutsi G; Stefani M; Chiti F; Zuccotti S; Bolognesi M; Viglino P
    Proteins; 2006 Jan; 62(1):64-79. PubMed ID: 16287076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein engineering as a strategy to avoid formation of amyloid fibrils.
    Villegas V; Zurdo J; Filimonov VV; Avilés FX; Dobson CM; Serrano L
    Protein Sci; 2000 Sep; 9(9):1700-8. PubMed ID: 11045616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apomyoglobin reveals a random-nucleation mechanism in amyloid protofibril formation.
    Fändrich M; Zandomeneghi G; Krebs MR; Kittler M; Buder K; Rossner A; Heinemann SH; Dobson CM; Diekmann S
    Acta Histochem; 2006; 108(3):215-9. PubMed ID: 16714052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and enzymatic investigation of the Sulfolobus solfataricus uridylate kinase shows competitive UTP inhibition and the lack of GTP stimulation.
    Jensen KS; Johansson E; Jensen KF
    Biochemistry; 2007 Mar; 46(10):2745-57. PubMed ID: 17297917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational studies of the structure, dynamics and native content of amyloid-like fibrils of ribonuclease A.
    Colombo G; Meli M; De Simone A
    Proteins; 2008 Feb; 70(3):863-72. PubMed ID: 17803210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfolobus solfataricus protein disulphide oxidoreductase: insight into the roles of its redox sites.
    Limauro D; Saviano M; Galdi I; Rossi M; Bartolucci S; Pedone E
    Protein Eng Des Sel; 2009 Jan; 22(1):19-26. PubMed ID: 18988690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation.
    Parrini C; Taddei N; Ramazzotti M; Degl'Innocenti D; Ramponi G; Dobson CM; Chiti F
    Structure; 2005 Aug; 13(8):1143-51. PubMed ID: 16084386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.